CA2370659A1 - Recepteur p2x3, methodes destinees a modifier l'activite d'un recepteur p2x3 et leurs utilisations - Google Patents
Recepteur p2x3, methodes destinees a modifier l'activite d'un recepteur p2x3 et leurs utilisations Download PDFInfo
- Publication number
- CA2370659A1 CA2370659A1 CA002370659A CA2370659A CA2370659A1 CA 2370659 A1 CA2370659 A1 CA 2370659A1 CA 002370659 A CA002370659 A CA 002370659A CA 2370659 A CA2370659 A CA 2370659A CA 2370659 A1 CA2370659 A1 CA 2370659A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor
- cell
- human
- polynucleotide
- atp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne un récepteur P2X¿3?, des méthodes destinées à moduler l'activité du récepteur P2X¿3? et les utilisations de ces méthodes. Ces méthodes peuvent, par exemple, être utilisées pour accélérer la resensibilisation d'un récepteur désensibilisé.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13033999P | 1999-04-21 | 1999-04-21 | |
US60/130,339 | 1999-04-21 | ||
PCT/US2000/010919 WO2000063379A2 (fr) | 1999-04-21 | 2000-04-21 | Recepteur p2x3, methodes destinees a modifier l'activite d'un recepteur p2x3 et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2370659A1 true CA2370659A1 (fr) | 2000-10-26 |
Family
ID=22444222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002370659A Abandoned CA2370659A1 (fr) | 1999-04-21 | 2000-04-21 | Recepteur p2x3, methodes destinees a modifier l'activite d'un recepteur p2x3 et leurs utilisations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1180141A2 (fr) |
JP (1) | JP2004500021A (fr) |
CA (1) | CA2370659A1 (fr) |
MX (1) | MXPA01010646A (fr) |
WO (1) | WO2000063379A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102659774A (zh) | 2005-08-15 | 2012-09-12 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3拮抗剂的哌啶和哌嗪衍生物 |
CA2624379A1 (fr) * | 2005-09-30 | 2007-04-12 | Merck & Co., Inc. | Acides nucleiques codant pour un recepteur purinergique fonctionnel de mammifere, p2x3, et leurs procedes de production et d'utilisation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2317449A1 (fr) * | 1998-01-16 | 1999-07-22 | Tim Van Biesen | Acides nucleiques codant un purinorecepteur fonctionnel humain p2x3 et procedes de production et d'utilisation de ces derniers |
-
2000
- 2000-04-21 EP EP00926289A patent/EP1180141A2/fr not_active Withdrawn
- 2000-04-21 JP JP2000612458A patent/JP2004500021A/ja active Pending
- 2000-04-21 CA CA002370659A patent/CA2370659A1/fr not_active Abandoned
- 2000-04-21 WO PCT/US2000/010919 patent/WO2000063379A2/fr not_active Application Discontinuation
- 2000-04-21 MX MXPA01010646A patent/MXPA01010646A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA01010646A (es) | 2002-05-06 |
WO2000063379A2 (fr) | 2000-10-26 |
EP1180141A2 (fr) | 2002-02-20 |
WO2000063379A3 (fr) | 2001-11-15 |
JP2004500021A (ja) | 2004-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xu et al. | Coassembly of TRP and TRPL produces a distinct store-operated conductance | |
Collo et al. | Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels | |
Archibald et al. | Surface expression and metabolic half-life of AMPA receptors in cultured rat cerebellar granule cells | |
US6323000B2 (en) | Variant human α7 acetylcholine receptor subunit, and methods of production and uses thereof | |
US20020086298A1 (en) | DNA encoding inward rectifier, G-protein activated, mammalian, potassium KGA channel and uses thereof | |
Meadows et al. | The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK | |
WO2007053526A1 (fr) | Compositions et methodes permettant d'identifier les modulateurs de trpv2 | |
US20100221773A1 (en) | Nucleic Acids Encoding a Functional Mammalin Purinoreceptor, P2X3, Methods of Production and Use Thereof | |
US6242216B1 (en) | Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof | |
US6214581B1 (en) | Nucleic acids encoding a functional human purinoreceptor P2X3 and P2X6, and methods of production and use thereof | |
CA2370659A1 (fr) | Recepteur p2x3, methodes destinees a modifier l'activite d'un recepteur p2x3 et leurs utilisations | |
US7547521B2 (en) | Heteromultimeric ion channel receptor and uses thereof | |
WO1999055901A2 (fr) | Technique de criblage fonctionnel de grande capacite servant a identifier des ligands de purinorecepteurs humains | |
JP2004500021A5 (fr) | ||
KR100851255B1 (ko) | G 단백질 커플된 수용체 | |
US6555341B1 (en) | Human theta subunit of the GABAa receptor | |
CA2339871A1 (fr) | Acides nucleiques codant un purinorecepteur fonctionnel humain p2x2, et procedes de production et d'utilisation de ce dernier | |
WO1999036539A1 (fr) | Acides nucleiques codant un purinorecepteur fonctionnel humain p2x3 et procedes de production et d'utilisation de ces derniers | |
US7229779B2 (en) | Variant human α7 acetylcholine receptor subunit, and methods of production and use thereof | |
EP1409680A2 (fr) | Nouveaux canaux a porte protonique humains | |
US20040115668A1 (en) | Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3 | |
US6635741B1 (en) | G-protein coupled receptor BCA-GPCR-3 | |
CA2432274A1 (fr) | Hcn3 de canal cationique declenche par des nucleotides cycliques et actives par hyperpolarisation chez l'homme | |
MXPA01001855A (en) | Nucleic acids encoding a functional human purinoreceptor p2x2 | |
US20050014141A1 (en) | Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |